3 New Stock Picks by Dan Loeb. Here’s a Quick Look at Each.

Dan Loeb vs Bill Ackman

Photo Credit: Left by STEVE MARCUS. Right by JACK CUSANO

Move over Mr Ackman.

Dan Loeb of Third Point is the new man in town taking the activist crown.

It’s funny because Ackman and Loeb are both billionaires, well regarded activist investors, once friends, but now labeled enemies.

I followed Ackman regularly starting from 2008. He is definitely a smart guy and the one that helped me get my first 1,000% return off GGP. I owe him big for that. But over the past couple of years, none of his picks have resonated with me.

Earlier in the year, I bought HLF after reading what he said and wrote, and again, I should thank him for that too.

Introducing Mr Loeb

Dan Loeb is the new investor to watch.

He moves deftly. He is a cold blooded hound when it comes to investing. And that’s what we need to witness.

While Ackman goes all in on one stock whether he is right or wrong, Loeb chooses his battles wisely.

What impressed me with Loeb is that he took a big position in HLF. Many viewed it as a way to get back at Ackman, but after the stock rose 50% from his purchase price, he promptly took his gains and moved on.

No chest beating at all.

That’s class.

So let’s take a look at 3 new stocks that fall into Mr Loeb’s Top 10.

Virgin Media Inc. (VMED)

Provides entertainment and communications services in the United Kingdom through broadband internet, television, and phone services.

  • Bought 11 million shares of Virgin Media in the first quarter
  • Total weighting of 10.1% in his portfolio

Virgin Media is Loeb’s second biggest position after Yahoo.

VMED has had a terrific run thanks to Liberty Global’s buyout. The deal is now approved and the company will be delisted.

This is a big win for Loeb. Although Third Point holds about 35 stocks, the top 5 is heavily concentrated.

  • 27.5% in Yahoo
  • 10.1% in VMED
  • 9.9% in AIG
  • 5.8% in IP
  • 3.7% in NWSA

As I mentioned at the beginning of this post, Dan Loeb is deft and that’s why I’m impressed with this transaction.

Accumulating 10.1% as a new position anticipating the closure of the merger is no easy task.

I said that for hedge funds, most companies fall into the illiquid category. Simply because these funds have a lot of cash and buying volume. Unless they want to start moving the market, patience and discipline must be observed.

That’s why you also have to read the guide to buying illiquid stocks.

With the merger over, let’s take a look at the numbers to see whether Liberty got a good deal.

VMED Valuation Ratios

VMED Valuation Ratios – old school value Stock Analyzer

Not bad. I removed PE since a company like VMED has too much leverage. Best to use EV/EBITDA in this type of situation for pretax and pre depreciation.

Although taxes and depreciation is a real part of the business, when it comes to buyouts, the company is merging into an existing business so excess fat will be eliminated and tax savings can occur.

The Piotroski score shows improvement in the business since the recession.

VMED Piotroski Score

VMED Piotroski Score – old school value Stock Analyzer

But with all the different business segments, accruals look to be a mess.

Best to check out whether there is anything to worry about.

VMED Accruals

VMED Accruals – old school value Stock Analyzer

Here’s a a quick pointer on interpreting the Sloan Ratio.

Sloan Ratio = (Net Income – CFO – CFI) / Total Assets

CFO = Cash From Operations

CFI = Cash From Investments

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

Read about the Sloan Ratio and accruals if you want to know what these numbers mean in deeper detail.

Tiffany & Co. (TIF)

Sells upscale jewelry.

  • Purchased 2.7 million shares of Tiffan
  • Sixth largest holding at 3.5% of his portfolio

Recession proof company.

Women with money will spend for the brand name or husbands/boyfriends will pay the extra price for that extra surprise factor.

I sure did.

TIF Selected Financials

TIF Selected Financials – old school value Stock Analyzer

TTM numbers are struggling, but there is nothing bad to say about the company as a whole.

Jewelry isn’t the quickest selling product and you can see that from the inventory turnover numbers.

TIF Fundamental Ratios

TIF Fundamental Ratios – old school value Stock Analyzer

But how well does TIF stack up against competitors?

TIF Competitors - old school value Stock Analyzer

TIF Competitors – old school value Stock Analyzer

Higher growth, stronger margins, better returns.

The one part that trips me up is the valuation. For a company with such stable margins, the bottom line free cash flow is wildly inconsistent. FCF is all over the place caused by increases in capital expenditures.

TIF Free Cash Flow - old school value Stock Analyzer

TIF Free Cash Flow – old school value Stock Analyzer

My estimate of intrinsic value is $60 on the low side to $80 on the high side.

B/E Aerospace Inc. (BEAV)

Makes cabin interior products for commercial aircraft and business jets worldwide.

  • Loaded up on 2 million shares
  • 10th largest holding
  • Average purchase price of $54

At the moment, BEAV isn’t the cheapest company to own.

For the line of business it’s in, I can’t justify the expected 20-25% growth that the market is expecting.

As a side note, for mostly all stock valuation methods that you use, you can do a “reverse” of it to find out the expectations.

A quick way to find the expected growth is to perform a reverse discounted cash flow or reverse Graham formula valuation.

It’s a great way to first value the company you normally would, and then to compare your numbers with what the market thinks.

Getting back to BEAV.

From an absolute valuation standpoint and using optimistic assumptions, I can see the intrinsic value ranging between the mid 40’s to 50’s.

Plus, most of the growth is coming through acquisitions.

YearAcquisitions ($M)

And because of this there is a lot of debt used to finance the acquisitions.

If acquisitions are smart, then taking on debt isn’t such a bad thing, but the company also has a habit of diluting the shares.

Although the dilution speed has slowed, it’s not as good as seeing a reduction.

YearDiluted Shares Outstanding (M)

I know I’m only looking at a few things here, but when looking at their financial statements, I don’t see any compelling value arguments to get me excited.

BEAV Fundamental Ratios

BEAV Fundamental and Valuation Ratios

So Dan Loeb added three stocks to his portfolio. Big new bets as all three are in the top 10 of his portfolio.

The difference could be his buy price and the current market price. If he bought at cheap enough prices, then it looks like a good deal, but at the moment, with so many other stocks out there, a quick look through VMED, TIF and BEAV doesn’t get me excited with any at the moment.

Click the image below to get a summarized tearsheet of all three stocks.

download stock analyzer summary

click to download summary

Disclosure: None

What is Old School Value?

Old School Value is a suite of value investing tools designed to fatten your portfolio by identifying what stocks to buy and sell.

It is a stock grader, value screener, and valuation tools for the busy investor designed to help you pick stocks 4x faster.

Check out the live preview of AMZN, MSFT, BAC, AAPL and FB.

Pick Winning Stocks and Fatten Your Portfolio